Neutrophil-to-lymphocyte ratio as a prognostic marker for lung cancer in combined pulmonary fibrosis and emphysema patients
The NLR may serve as a cost-effective and widely accessible biomarker for risk stratification, particularly in CPFE patients with advanced-stage LC. In our cohort, an NLR cutoff value of 2.6 provides improved prognostic accuracy in predicting mortality outcomes.
Authors
- Weiping Xie (ORCID: https://orcid.org/0000-0002-6011-0143)
- Linling Jin
- Shulan Zhou (ORCID: https://orcid.org/0000-0002-2980-2205)
- Jiayi Zhang (ORCID: https://orcid.org/0000-0002-1575-0723)
- Ling Chen (ORCID: https://orcid.org/0000-0003-1485-1626)
- Yiting He (ORCID: https://orcid.org/0009-0002-5705-618X)
- Mengyu He
- Hui Kong (ORCID: https://orcid.org/0000-0001-9547-0408)
- Lei Huang (ORCID: https://orcid.org/0000-0001-6770-6399)
Institutions
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1186/s40001-025-02595-3
- Citations
- 4
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 6.07
Funders
- Government of Jiangsu Province
- Nanjing Medical University